Drug-eluting stents for the treatment of coronary artery disease
KEYWORDS: patients, dess, group, des, bms, data, assessment, price, risk, assessment group, compared, ses, committee, pes, months

guidance. 5.3 When NICE recommends a treatment 'as an option', the NHS must make sure it is available within the period set out in the paragraphs above. This means that, if a patient has coronary artery disease and the healthcare professional responsible for their care thinks that drug-eluting stents is the right treatment, it should be available for use, in line with NICE's recommendations.
